Posted inMedical Technology
Illumina hires former NHGRI Director Eric Green as new chief medical officer
Nearly a year after leaving his position as longtime director of the National Human Genome Research Institute (NHGRI), Eric Green,…
Posted inMedical Technology
Quest, Labcorp add fully at-home STI test to women’s health offerings
Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one…
Posted inMedical Technology
Startup Spiro Medical snares $67M in series A funding for asthma treatment
Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop…
Posted inMedical Technology
Lexeo Therapeutics, J&J team up to test heart pump technology for cardiac gene therapy delivery
Lexeo Therapeutics is teaming up with Big Pharma Johnson & Johnson's unit Abiomed to tap its Impella heart pump technology…
Posted inMedical Technology
Staar Surgical’s takeover saga ends as shareholder revolt stops Alcon’s attempted merger deal
Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now…
Posted inMedical Technology
BrainSpace garners FDA clearance for brain fluid management system
BrainSpace, a medtech focused on neurological injuries and illnesses, received 501(k) clearance from the FDA for its brain fluid management…
Posted inMedical Technology
Naox Technologies nabs 1st FDA clearance for in-ear EEG brain monitoring device
Naox Technologies has become the first medtech company to receive FDA clearance for its in-ear EEG device that can negate…
Posted inMedical Technology
Abbott launches AI-based Libre Assist, its new in-app feature for meal planning
Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s…
Posted inMedical Technology
Biobeat Technologies drums up $50M for its cuffless blood pressure monitor
Biobeat Technologies has raised $50 million in a series B round to help boost the commercialization of its blood pressure…
Posted inMedical Technology
Insilico, fresh off its Hong Kong IPO, pens potential $888M cancer R&D pact with Servier
Right on the heels of its IPO, Insilico Medicine is starting the year with an oncology discovery and development pact…